nodes	percent_of_prediction	percent_of_DWPC	metapath
Dimenhydrinate—HRH1—Histamine receptors—HRH3—attention deficit hyperactivity disorder	0.0942	0.098	CbGpPWpGaD
Dimenhydrinate—HRH1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0256	0.0267	CbGpPWpGaD
Dimenhydrinate—CHRM2—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0252	0.0263	CbGpPWpGaD
Dimenhydrinate—HRH1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0251	0.0261	CbGpPWpGaD
Dimenhydrinate—CHRM2—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0247	0.0257	CbGpPWpGaD
Dimenhydrinate—HRH1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0216	0.0224	CbGpPWpGaD
Dimenhydrinate—CHRM2—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0212	0.0221	CbGpPWpGaD
Dimenhydrinate—HRH1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0211	0.022	CbGpPWpGaD
Dimenhydrinate—CHRM2—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0208	0.0216	CbGpPWpGaD
Dimenhydrinate—Diphenylpyraline—SLC6A3—attention deficit hyperactivity disorder	0.0167	0.428	CrCbGaD
Dimenhydrinate—HRH1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0152	0.0158	CbGpPWpGaD
Dimenhydrinate—CHRM2—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.015	0.0156	CbGpPWpGaD
Dimenhydrinate—HRH1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0146	0.0152	CbGpPWpGaD
Dimenhydrinate—CHRM2—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0144	0.015	CbGpPWpGaD
Dimenhydrinate—HRH1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0142	0.0147	CbGpPWpGaD
Dimenhydrinate—CHRM2—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.0139	0.0145	CbGpPWpGaD
Dimenhydrinate—HRH1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0137	0.0143	CbGpPWpGaD
Dimenhydrinate—CHRM2—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0135	0.014	CbGpPWpGaD
Dimenhydrinate—HRH1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0135	0.014	CbGpPWpGaD
Dimenhydrinate—HRH1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0133	0.0138	CbGpPWpGaD
Dimenhydrinate—CHRM2—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0133	0.0138	CbGpPWpGaD
Dimenhydrinate—CHRM2—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0131	0.0136	CbGpPWpGaD
Dimenhydrinate—Benzatropine—SLC6A3—attention deficit hyperactivity disorder	0.0128	0.328	CrCbGaD
Dimenhydrinate—HRH1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0128	0.0133	CbGpPWpGaD
Dimenhydrinate—CHRM2—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0126	0.0131	CbGpPWpGaD
Dimenhydrinate—HRH1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0124	0.0129	CbGpPWpGaD
Dimenhydrinate—CHRM2—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0122	0.0127	CbGpPWpGaD
Dimenhydrinate—HRH1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0119	0.0124	CbGpPWpGaD
Dimenhydrinate—CHRM2—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0117	0.0122	CbGpPWpGaD
Dimenhydrinate—HRH1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0115	0.012	CbGpPWpGaD
Dimenhydrinate—CHRM2—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0113	0.0118	CbGpPWpGaD
Dimenhydrinate—HRH1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.0113	0.0118	CbGpPWpGaD
Dimenhydrinate—HRH1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0112	0.0116	CbGpPWpGaD
Dimenhydrinate—CHRM2—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.0111	0.0116	CbGpPWpGaD
Dimenhydrinate—CHRM2—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.011	0.0115	CbGpPWpGaD
Dimenhydrinate—HRH1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0104	0.0108	CbGpPWpGaD
Dimenhydrinate—CHRM2—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0103	0.0107	CbGpPWpGaD
Dimenhydrinate—Modafinil—SLC6A3—attention deficit hyperactivity disorder	0.00949	0.243	CrCbGaD
Dimenhydrinate—HRH1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00868	0.00903	CbGpPWpGaD
Dimenhydrinate—CHRM2—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.00854	0.00889	CbGpPWpGaD
Dimenhydrinate—CHRM2—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.00782	0.00814	CbGpPWpGaD
Dimenhydrinate—HRH1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.0073	0.00759	CbGpPWpGaD
Dimenhydrinate—CHRM2—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.00718	0.00747	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCRs, Other—DRD3—attention deficit hyperactivity disorder	0.00599	0.00623	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCRs, Other—DRD4—attention deficit hyperactivity disorder	0.00582	0.00605	CbGpPWpGaD
Dimenhydrinate—CHRM2—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00525	0.00546	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.00503	0.00523	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00495	0.00515	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00487	0.00507	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00485	0.00505	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00481	0.00501	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00477	0.00496	CbGpPWpGaD
Dimenhydrinate—CHRM2—Calcium Regulation in the Cardiac Cell—CACNA1C—attention deficit hyperactivity disorder	0.00477	0.00496	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00474	0.00493	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.00432	0.0045	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00424	0.00441	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00417	0.00434	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00415	0.00432	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00409	0.00425	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.00402	0.00418	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.00402	0.00418	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCRs, Other—HTR2A—attention deficit hyperactivity disorder	0.00379	0.00395	CbGpPWpGaD
Dimenhydrinate—CHRM2—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00356	0.00371	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00336	0.0035	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00331	0.00344	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00323	0.00336	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00318	0.00331	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00316	0.00329	CbGpPWpGaD
Dimenhydrinate—CHRM2—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00311	0.00324	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00311	0.00324	CbGpPWpGaD
Dimenhydrinate—HRH1—IL-4 Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.0031	0.00323	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00302	0.00315	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00294	0.00306	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00292	0.00304	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00289	0.00301	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00288	0.003	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00283	0.00295	CbGpPWpGaD
Dimenhydrinate—CHRM2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.0028	0.00292	CbGpPWpGaD
Dimenhydrinate—CHRM2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00276	0.00287	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00273	0.00284	CbGpPWpGaD
Dimenhydrinate—CHRM2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00272	0.00283	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00272	0.00283	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00269	0.0028	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00268	0.00279	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00265	0.00275	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.0026	0.00271	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.0026	0.00271	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00257	0.00267	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00256	0.00266	CbGpPWpGaD
Dimenhydrinate—CHRM2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00254	0.00264	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00253	0.00263	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00252	0.00262	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00248	0.00258	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00247	0.00257	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00247	0.00257	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00243	0.00253	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00239	0.00249	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00235	0.00245	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00234	0.00243	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.0023	0.0024	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00227	0.00236	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00223	0.00232	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00223	0.00232	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.0022	0.00229	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00219	0.00228	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00219	0.00228	CbGpPWpGaD
Dimenhydrinate—HRH1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00217	0.00226	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00216	0.00225	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00216	0.00225	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00205	0.00213	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00202	0.0021	CbGpPWpGaD
Dimenhydrinate—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00194	0.00202	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00192	0.00199	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00189	0.00196	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00182	0.0019	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.0018	0.00187	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00179	0.00186	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00178	0.00185	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00176	0.00183	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00175	0.00182	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00173	0.0018	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.0017	0.00177	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.0017	0.00177	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00168	0.00174	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00168	0.00174	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00167	0.00174	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00166	0.00172	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00165	0.00172	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00165	0.00172	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00163	0.0017	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00162	0.00169	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.0016	0.00166	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00156	0.00162	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00154	0.0016	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00146	0.00152	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00144	0.00149	CbGpPWpGaD
Dimenhydrinate—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00144	0.00149	CbGpPWpGaD
Dimenhydrinate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00141	0.00147	CbGpPWpGaD
Dimenhydrinate—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.00131	0.00136	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00124	0.00129	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00122	0.00127	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00114	0.00119	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00113	0.00117	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00112	0.00117	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00111	0.00115	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00109	0.00114	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00108	0.00113	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00108	0.00112	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00107	0.00111	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00101	0.00105	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000991	0.00103	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000984	0.00102	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000979	0.00102	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000975	0.00101	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000968	0.00101	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000963	0.001	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00096	0.000999	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000959	0.000998	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000959	0.000997	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000947	0.000985	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000944	0.000982	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000943	0.000982	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00094	0.000979	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000932	0.000969	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000925	0.000963	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000914	0.000952	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.0009	0.000936	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000886	0.000922	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000882	0.000918	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000871	0.000907	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00087	0.000906	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000868	0.000903	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00086	0.000895	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000857	0.000891	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000846	0.00088	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000801	0.000833	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000788	0.00082	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000665	0.000692	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000654	0.000681	CbGpPWpGaD
Dimenhydrinate—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000618	0.000643	CbGpPWpGaD
Dimenhydrinate—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000608	0.000632	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000581	0.000605	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000572	0.000595	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000561	0.000584	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000552	0.000574	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00054	0.000562	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000532	0.000553	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000523	0.000544	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000515	0.000536	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000514	0.000535	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000508	0.000528	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000506	0.000527	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.0005	0.00052	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000473	0.000492	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000466	0.000484	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000331	0.000345	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000326	0.000339	CbGpPWpGaD
Dimenhydrinate—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000176	0.000183	CbGpPWpGaD
Dimenhydrinate—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000173	0.00018	CbGpPWpGaD
